Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Feb 2019. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
112517701000001114 | Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices 3 pre-filled disposable injection (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
112517801000001117 | Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices 3 pre-filled disposable injection | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices 3 pre-filled disposable injection | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices 3 pre-filled disposable injection | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices 3 pre-filled disposable injection | Has VMP | Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices | true | Inferred relationship | Existential restriction modifier | ||
Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices 3 pre-filled disposable injection | VMP prescribing status (attribute) | VMP not recommended to prescribe - patient training required | false | Inferred relationship | Existential restriction modifier | ||
Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices 3 pre-filled disposable injection | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices 3 pre-filled disposable injection | Has specific active ingredient | Lixisenatide | true | Inferred relationship | Existential restriction modifier | ||
Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices 3 pre-filled disposable injection | Has specific active ingredient | Insulin glargine | true | Inferred relationship | Existential restriction modifier | ||
Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices 3 pre-filled disposable injection | Has dispensed dose form | Conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices 3 pre-filled disposable injection | VMP prescribing status (attribute) | Caution - AMP level prescribing advised | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Suliqua 100units/ml / 33micrograms/ml solution for injection 3ml pre-filled SoloStar pens (Sanofi) 3 pre-filled disposable injection | Is a | True | Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices 3 pre-filled disposable injection | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets